References
- Buetti N, Atkinson A, Marschall J, et al. Swiss Centre for Antibiotic R. Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008–2014. BMJ Open. 2017;7:e013665.
- Lindvig KP, Nielsen SL, Henriksen DP, et al. Mortality and prognostic factors of patients who have blood cultures performed in the emergency department: a cohort study. Eur J Intern Med. 2016;23:166–172.
- Yo CH, Lee MG, Hsein YC, et al. Risk factors and outcomes of afebrile bacteremia patients in an emergency department. Diagn Microbiol Infect Dis. 2016;86:455–459.
- Zasowski EJ, Claeys KC, Lagnf AM, et al. Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections. Clin Infect Dis. 2016;62:1242–1250.
- Liaudat S, Dayer E, Praz G, et al. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis. 2001;20:524–527.
- Aikawa N, Fujishima S, Endo S, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005;11:152–159.
- Viallon A, Guyomarc'h S, Marjollet O, et al. Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin. Eur J Emerg Med. 2008;15:26–33.
- Riedel S, Melendez JH, An AT, et al. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol. 2011;135:182–189.
- Hattori T, Nishiyama H, Kato H, et al. Clinical value of procalcitonin for patients with suspected bloodstream infection. Am J Clin Pathol. 2014;141:43–51.
- Kim SY, Jeong TD, Lee W, et al. Procalcitonin in the assessment of bacteraemia in emergency department patients: results of a large retrospective study. Ann Clin Biochem. 2015;52:654–659.
- Pan YP, Fang YP, Xu YH, et al. The diagnostic value of procalcitonin versus other biomarkers in prediction of bloodstream infection. Clin Lab. 2017;63:277–285.
- Yan ST, Sun LC, Jia HB, et al. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Am J Emerg Med. 2017;35:579–583.
- Arora R, Campbell JP, Simon G, et al. Does serum procalcitonin aid in the diagnosis of bloodstream infection regardless of whether patients exhibit the systemic inflammatory response syndrome? Infection. 2017;45:291–298.
- Cochon L, Ovalle A, Nicolas JM, et al. Acute Care Diagnostic Collaboration: *Bayesian modeling comparative diagnostic assessment of lactate, procalcitonin and CRP in risk stratified population by Mortality in ED (MEDS) score. Am J Emerg Med. 2017;35:564–568.
- Freund Y, Delerme S, Goulet H, et al. Serum lactate and procalcitonin measurements in emergency room for the diagnosis and risk-stratification of patients with suspected infection. Biomarkers. 2012;17:590–596.
- Lin CT, Lu JJ, Chen YC, et al. Diagnostic value of serum procalcitonin, lactate, and high-sensitivity C-reactive protein for predicting bacteremia in adult patients in the emergency department. PeerJ. 2017;5:e4094.
- Liu HH, Zhang MW, Guo JB, et al. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria. Ir J Med Sci. 2017;186:207–212.
- Ljungstrom L, Pernestig AK, Jacobsson G, et al. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One. 2017;12:e0181704.
- Miglietta F, Faneschi ML, Lobreglio G, et al. Procalcitonin, C-reactive protein and serum lactate dehydrogenase in the diagnosis of bacterial sepsis, SIRS and systemic candidiasis. Infez Med. 2015;23:230–237.
- Milone MT, Kamath AF, Israelite CL. Converting between high- and low-sensitivity C-reactive protein in the assessment of periprosthetic joint infection. J Arthroplasty. 2014;29:685–689.
- Windgassen EB, Funtowicz L, Lunsford TN, et al. C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med. 2011;123:114–119.
- Castelli GP, Pognani C, Meisner M, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8:R234–R242.
- Julian-Jimenez A, Gutierrez-Martin P, Lizcano-Lizcano A, et al. Usefulness of procalcitonin and C-reactive protein for predicting bacteremia in urinary tract infections in the emergency department. Actas Urol Esp. 2015;39:502–510.
- Leli C, Cardaccia A, Ferranti M, et al. Procalcitonin better than C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in predicting DNAemia in patients with sepsis. Scand J Infect Dis. 2014;46:745–752.
- Nishikawa H, Shirano M, Kasamatsu Y, et al. Comparison between procalcitonin and C-reactive protein in predicting bacteremias and confounding factors: a case-control study. Clin Chem Lab Med. 2017;55:1043–1052.
- Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.
- DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845.
- Leal SM Jr, Jones M, Gilligan PH. Clinical significance of commensal Gram-Positive Rods routinely isolated from patient samples. J Clin Microbiol. 2016;54:2928–2936.
- Wang T, Cui YL, Lin ZF, et al. Comparative study of plasma endotoxin with procalcitonin levels in diagnosis of bacteremia in intensive care unit patients. Chin Med J (Engl). 2016;129:417–423.
- Takeshima T, Yamamoto Y, Noguchi Y, et al. Identifying patients with bacteremia in community-hospital emergency rooms: a Retrospective Cohort Study. PLoS One. 2016;11:e0148078.
- Schuetz P, Mueller B, Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection. 2007;35:352–355.
- Glas AS, Lijmer JG, Prins MH, et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56:1129–1135.
- Eusebi P. Diagnostic accuracy measures. Cerebrovasc Dis. 2013;36:267–272.
- McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002;17:646–649.
- Freemantle N. StatsDirect—Statistical software for medical research in the 21st century. BMJ. 2000;321:1536.
- Yildiz B, Poyraz H, Cetin N, et al. High sensitive C-reactive protein: a new marker for urinary tract infection, VUR and renal scar. Eur Rev Med Pharmacol Sci. 2013;17:2598–2604.
- Su YJ, Liao SC, Cheng BC, et al. Increasing high-sensitive C-reactive protein level predicts peritonitis risk in chronic peritoneal dialysis patients. BMC Nephrol. 2013;14:185.
- Lee CC, Wu CJ, Chi CH, et al. Prediction of community-onset bacteremia among febrile adults visiting an emergency department: rigor matters. Diagn Microbiol Infect Dis. 2012;73:168–173.